Vertex Pharmaceuticals Price Target Raised to $612 Morgan Stanley raised Vertex's price target to $612 from $596 on Apr 11, 2026 (a 2.7% increase); implications for its CF franchise and pipeline valuation are explored.

Vertex Pharmaceuticals Price Target Raised to $612: Morgan Stanley raised Vertex's price target to $612 from $596 on Apr 11, 2026 (a 2.7% increase); implications for its CF franchise and… 👈 Read full analysis #VertexPharmaceuticals #MorganStanley #Pharmaceuticals #HealthcareInvesting #StockMarket

Transformative Research in Cystic Fibrosis | NEJM Michael Welsh, Jesús González, and Paul Negulescu have won the 2025 Lasker–DeBakey Clinical Medical Research Award for their roles in developing treatments for cystic fibrosis.

“In a remarkable convergence of a pressing therapeutic need and highly specialized technology,” #LaskerAward winners Negulescu & González #VertexPharmaceuticals "fashioned a personalized approach to therapeutic development.” #cysticfibrosis #Lasker2025 🧪

#LaskerAward winners Michael Welsh, Jesús (Tito) González, and Paul Negulescu developed a triple-drug combination treatment for #cysticfibrosis. Their work transformed a lethal disease into a manageable condition. #Lasker2025 #UniversityofIowa #VertexPharmaceuticals 🧪

Vertex, CRISPR Therapeutics Land On TIME's Most Influential Companies List - IndiaWest Journal News Vertex, CRISPR Therapeutics Land On TIME's Most Influential Companies List.

Vertex, CRISPR Therapeutics Land On TIME's Most Influential Companies List

Full Story: indiawest.com/vertex-crisp...

#VertexPharmaceuticals #CRISPRTherapeutics #Casgevy #SickleCellTreatment #BetaThalassemiaCure #GeneEditingInnovation #FDAApprovedTherapy #ExaCel

Vertex Pharmaceuticals hiring Director, Chemistry Technology in Boston, MA | LinkedIn Posted 5:52:23 PM. Job DescriptionGeneral Summary:Vertex is a global biotechnology company that invests in scientific…See this and similar jobs on LinkedIn.

An amazing opportunities on my team at #VertexPharmaceuticals I’m looking for a Director in Chemistry Technology for research and preclinical #Chemsky #Chemistry #IT #Data www.linkedin.com/jobs/view/42... coming soon is another director level role in #HPC and data @chemjobber.bsky.social

Reshma Kewalramani Among TIME’s 100 Most Influential People Of 2025 - IndiaWest Journal News Reshma Kewalramani Among TIME’s 100 Most Influential People Of 2025.

Reshma Kewalramani Among TIME’s 100 Most Influential People Of 2025

Full Story: indiawest.com/reshma-kewal...

#ReshmaKewalramani #TIME100 #MostInfluentialPeople2025 #VertexPharmaceuticals #BiotechLeader #WomenInSTEM #IndianAmericanLeaders

Painkillers without the addiction? The new wave of non-opioid pain relief Pharma firms are developing drugs that avoid the brain’s opioid receptors to minimise the risks of dependence and overdoses, but not all experts are convinced

#pain #nonopioidpainrelief #drugdevelopment #suzetrigine #VertexPharmaceuticals #Vertex #Journavx #nonaddictivepainkiller #nociceptivepain #neuropathicpain #Nociplasticpain #chronicpain #dopamine #dopaminedump #VertexPharmaceuticals #TrisPharma #Vertanical
www.theguardian.com/science/2025...

Discovering Suzetrigine: A New Era in Pain Relief Suzetrigine: A Safer Nonopioid Analgesic In the ever-evolving world of pain management, a groundbreaking development has emerged that could change the landscape of treatment for millions of individuals suffering from acute pain. Suzetrigine, the first nonopioid analgesic approved by the FDA in 25 years, is generating excitement among pain specialists like Dr. Brett Stacey, a seasoned expert in the field and a professor of anesthesiology and pain medicine at the University of Washington School of Medicine.

READ FULL ARTICLE ON PAIN ON-LINE: #Suzetrigine #NonopioidAnalgesic #PainManagement #FDAApproval #AcutePain #PainRelief #ClinicalTrials #SodiumChannels #VertexPharmaceuticals #ChronicPain #OpioidAlternatives #PatientSafety #QualityOfLife #InnovativeTreatments #Pain #Medicine #Opioid